Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)

Author(s):  Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice

Issue:  Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue

Page(s):  150-154

Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Page 1
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Page 2
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Page 3
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Page 4
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Page 5

Download in electronic PDF format for $75

Abstract:  Fludrocortisone acetate is a drug used to treat adrenal insufficiencies which can be prescribed to hospitalized or ambulatory pediatric patients at dosages not commercially available. For these patients, 10-µg fludrocortisone capsules are currently compounded from a pre-compounded titrated powder (powder triturate). Fludrocortisone stability studies were carried out to ensure a valid beyond-use date. First, a stability-indicating fludrocortisone acetate dosing method was validated. Then fludrocortisone acetate 10-µg capsules and 1% fludrocortisone acetate titrated powders (powder triturates) were realized. Finally, stability studies were performed. The fludrocortisone acetate titrated powders (powder triturates) were stable for one year at controlled ambient temperature and protected from light, whereas 10-µg fludrocortisone acetate capsules were stable for six months. One year after, even if the fludrocortisone content remained conformed, an increase in product degradation was noted. Our work allowed us to determine a six-month beyond-use date for fludrocortisone acetate titrated powder (powder triturate) with the three most commonly used excipients for capsule compounding. We also confirmed the sixmonth theoretical stability for capsules.

Related Keywords: fludrocortisone acetate, stability, adrenocortical insufficiency, adrenal deficiency, excipients, titrated powders, powder triturates, children

Related Categories: EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut
, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022
Pg. 150-154

The Basics of Compounding Powders and Granules
Allen Loyd V Jr
Jan/Feb 2001
Pg. 36-39

Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety
Prince Bryan
, Lundevall Jeremy
May/Jun 2014
Pg. 222-226

Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
Jan/Feb 2014
Pg. 42-45

Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations
Allen Loyd V Jr
Jan/Feb 2001
Pg. 38

Menthol Dusting Powder-Example of Powder Formulations
Allen Loyd V Jr
Jan/Feb 2001
Pg. 38

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin
, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2022
Pg. 255-263

A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
May/Jun 2022
Pg. 195-200

Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle
, Dozzi Raphael
Sep/Oct 2018
Pg. 369-384

Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder
Gupta Vishnu D
Sep/Oct 2003
Pg. 386-388

Dexamethasone Oral Powder 10-mg Units, Veterinary
Allen Loyd V Jr
May/Jun 2005
Pg. 226

Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 229

Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
Jul/Aug 2008
Pg. 355

Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets
Allen Loyd V Jr
Jan/Feb 2009
Pg. 64

Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 65

Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder
Allen Loyd V Jr
Jan/Feb 2009
Pg. 72

Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding
Zhao Fang
, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
Sep/Oct 2018
Pg. 433-439

Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 501

Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration
Chan Pak
, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2008
Pg. 276-278

Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink
Donnelly Ronald F
Nov/Dec 2004
Pg. 489-491

Return to Top